The structure and biological activities of the widely used protein kinase inhibitor, H7, differ depending on the commercial source.
The protein kinase inhibitor 1-(5'-isoquinolinesulfonyl)-2-methylpiperazine (H7) has been widely used because of its ability to inhibit cyclic AMP- and cyclic GMP-dependent protein kinases (PKA and PKG) and protein kinase C (PKC) at roughly equal concentrations; it is much less potent on other kinases. Previous studies in other laboratories have found that H7 samples from different commercial sources have different properties in cellular studies and protein kinase C inhibition assays. We now report the results of chemical and biological tests which show that H7 samples also differ in chemical structure, again depending on their commercial source. Chemical synthesis and NMR spectroscopy indicate that H7 from most suppliers has the structure originally proposed for H7, while "H7" from another supplier is in fact its 3-methylpiperazine positional isomer.
Quick
J
J
Alder Research Center, Woburn, MA 01801.
Ware
J A
JA
Driedger
P E
PE
D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; D007546:Isoquinolines / Q000737:chemistry / Q000494:pharmacology / Q000592:standards*; D009682:Magnetic Resonance Spectroscopy; D015394:Molecular Structure; D010879:Piperazines / Q000737:chemistry / Q000494:pharmacology / Q000592:standards*; D047428:Protein Kinase Inhibitors
D007546:Isoquinolines; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine